What is the initial work‑up for a patient suspected of having Cushing's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Initial Work-Up for Suspected Cushing's Disease

Begin by obtaining a detailed medication history to exclude exogenous glucocorticoid exposure from oral, inhaled, topical, or injected sources before ordering any biochemical tests. 1, 2

First-Line Screening Tests

You must perform at least two different screening tests to confirm the diagnosis before proceeding to imaging or localization studies. 3, 2 Choose from the following based on patient-specific factors:

24-Hour Urinary Free Cortisol (UFC)

  • Collect at least two to three separate 24-hour urine samples on different days to account for day-to-day variability. 1, 2, 4
  • Verify adequate collection by checking urinary creatinine excretion. 4
  • **Avoid UFC if creatinine clearance is <60 mL/min** or if the patient has marked polyuria (>5 L/24 hours), as results become unreliable. 2, 4
  • UFC values >3-fold the upper limit of normal strongly suggest true Cushing's syndrome rather than pseudo-Cushing states. 2

Late-Night Salivary Cortisol (LNSC)

  • Collect at least two samples between 11 PM and midnight on separate nights. 1, 2
  • This test is preferred for shift workers, suspected cyclic Cushing's syndrome, and outpatient convenience because it captures loss of the normal circadian rhythm. 2
  • LNSC is particularly useful when UFC collection is impractical or unreliable. 1, 2

1-mg Overnight Dexamethasone Suppression Test (DST)

  • Administer 1 mg dexamethasone at 11 PM and measure serum cortisol at 8 AM the next morning. 1, 2
  • A cortisol level >1.8 µg/dL (50 nmol/L) indicates Cushing's syndrome. 2
  • Preferred for patients with renal failure (when UFC is unreliable) and for evaluating adrenal incidentalomas. 2
  • Measure serum dexamethasone levels concurrently to reduce false-positive results from non-compliance or altered drug metabolism. 1, 2

Critical Test Selection Considerations

Avoid or interpret with extreme caution in these situations:

  • Women taking oral estrogen: Estrogen increases corticosteroid-binding globulin (CBG), causing falsely elevated cortisol in DST; use UFC or LNSC instead. 2, 4
  • Patients on CYP3A4 inducers (phenobarbital, carbamazepine, phenytoin, St. John's wort): These accelerate dexamethasone metabolism, causing false-negative DST results; use UFC or LNSC. 2
  • Pregnancy: Use only UFC; DST is contraindicated. 2, 5
  • Suspected cyclic Cushing's syndrome: Prefer UFC or multiple LNSC measurements over DST to capture intermittent hypercortisolism. 2, 5

Interpretation Algorithm

Concordant Positive Results (≥2 abnormal tests)

  • Immediately refer to endocrinology and proceed with ACTH measurement to determine whether the cause is ACTH-dependent (pituitary or ectopic) or ACTH-independent (adrenal). 1, 2, 5
  • Exclude pseudo-Cushing states (severe obesity, depression, alcohol use disorder, PCOS) before proceeding to imaging, as these conditions typically cause UFC elevations <3-fold the upper limit of normal. 2

Concordant Negative Results (≥2 normal tests)

  • Cushing's syndrome is unlikely; no further work-up is needed. 3, 2
  • Exception: If clinical suspicion remains high (e.g., progressive symptoms, adrenal incidentaloma with suggestive features), refer to endocrinology and consider re-evaluation in 6 months. 2, 5

Discordant Results (one positive, one negative)

  • Obtain a third screening test or consider specialized tests such as midnight serum cortisol or dexamethasone-CRH test. 3, 2
  • Refer to endocrinology for expert interpretation, especially if pretest probability is high. 3, 2

Common Pitfalls to Avoid

  • Never rely on a single abnormal screening test before proceeding to imaging or invasive procedures. 2, 5
  • Do not use random serum cortisol, plasma ACTH, or urinary 17-ketosteroids for initial screening. 2, 5
  • Incomplete 24-hour urine collections invalidate UFC results; always verify collection adequacy with urinary creatinine. 4
  • Pseudo-Cushing states (obesity, depression, alcohol use, PCOS) can mimic Cushing's syndrome biochemically but typically show UFC elevations <3-fold normal. 2
  • Oral estrogen therapy, pregnancy, and chronic active hepatitis raise CBG and can falsely elevate total serum cortisol in DST. 4

Next Steps After Biochemical Confirmation

Once two concordant positive screening tests confirm hypercortisolism:

  1. Measure plasma ACTH to differentiate ACTH-dependent (normal or high ACTH) from ACTH-independent (low ACTH) causes. 1
  2. If ACTH is normal or elevated: Obtain pituitary MRI to look for an adenoma. 1
    • Lesions ≥10 mm are presumed Cushing's disease and do not require inferior petrosal sinus sampling (IPSS). 1
    • Lesions <6 mm require IPSS for confirmation. 1
    • Lesions 6–9 mm fall into a gray zone where expert opinion differs; consider CRH/DDAVP testing or IPSS. 1
  3. If ACTH is low: Obtain adrenal CT or MRI to identify an adrenal source. 1

References

Guideline

Workup to Rule Out Cushing Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

the diagnosis of cushing's syndrome: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2008

Guideline

Urgent Evaluation and Management of ACTH‑Independent Cushing Syndrome with Concurrent Hyperinsulinemic Hypoglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guidelines for Ordering and Interpreting Cortisol Tests in Suspected Cushing’s Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.